538
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Predictive factors for structural remission using abatacept: Results from the ABROAD study

, , , , , , , , , , & show all
Pages 406-412 | Received 20 Dec 2017, Accepted 24 May 2018, Published online: 27 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ryu Watanabe, Kosaku Murakami, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Akio Morinobu & Motomu Hashimoto. (2023) Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort. Immunological Medicine 46:2, pages 84-92.
Read now

Articles from other publishers (4)

Yoshiya Tanaka, Tsutomu Takeuchi, Yoshiaki Morita, Daisuke Kato, Yuichiro Kaneko & Wataru Terada. (2023) Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4) . Modern Rheumatology.
Crossref
Kenta Misaki, Naoto Tamura, Takanori Azuma, Koichiro Shinoda, Masao Tanaka, Hiroshi Fujiwara, Hideki Tsuboi, Tsuyoshi Kasama, Ryusuke Yoshimi, Tadamasa Hanyu, Yoshiaki Kusaka, Makoto Hirao, Makoto Onishi, Ayumi Uchino, Tomomasa Izumiyama, Kwang-Seok Yang, Noriyoshi Ogawa, Kiyoshi Matsui, Kazuhiro Kurasawa, Satoshi Kawaai, Hidekata Yasuoka, Noriaki Okumura, Yo Ueda, Eiichi Tanaka, Eisuke Inoue, Katsuki Tsuritani, Shigeru Matsumoto, Hisashi Yamanaka & Masayoshi Harigai. (2023) Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI) . Modern Rheumatology.
Crossref
Yasmin Khader, Azizullah Beran, Sami Ghazaleh, Wade Lee-Smith & Nezam Altorok. (2022) Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis. Clinical Rheumatology 41:12, pages 3615-3627.
Crossref
Andrea Rubbert-Roth, Daniel Aletaha, Jenny Devenport, Paris N Sidiropoulos, Yves Luder, Michael D Edwardes & Johannes W G Jacobs. (2021) Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. Rheumatology 60:2, pages 682-691.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.